Study of the Efficacy, Biodistribution, and Safety Profile of Therapeutic Gutless Adenovirus Vectors as a Prelude to a Phase I Clinical Trial for Glioblastoma

Lignende værker

• A Novel Bicistronic High-Capacity Gutless Adenovirus Vector That Drives Constitutive Expression of Herpes Simplex Virus Type 1 Thymidine Kinase and Tet-Inducible Expression of Flt3L for Glioma Therapeutics
  af: Puntel, Mariana, et al.
  Udgivet: (2010)
• Immunization Against the Transgene but not the TetON Switch Reduces Expression From Gutless Adenoviral Vectors in the Brain
  af: Xiong, Weidong, et al.
  Udgivet: (2008)
• Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety
  af: Candolfi, Marianela, et al.
  Udgivet: (2009)
• Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase 1 Clinical Trial
  af: Ghulam Muhammad, A.K.M., et al.
  Udgivet: (2012)
• Safety Profile, Efficacy, and Biodistribution of a Bicistronic High-Capacity Adenovirus Vector Encoding a Combined Immunostimulation and Cytotoxic Gene Therapy as a Prelude to a Phase I Clinical Trial for Glioblastoma
  af: Puntel, Mariana, et al.
  Udgivet: (2013)